Adaptimmune Therapeutics Plc ADR (ADAP): The stock short term indicators tell us to Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw downtrend of 0.00% in the recent trading with $1.44 being its most recent. The current price level -29.76% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 242.86% higher than the lowest price of $0.42 the company dropped […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock long term indicators say Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 7.46% in the recent trading with $1.44 being its most recent. The current price level -29.76% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 242.86% higher than the lowest price of $0.42 the company […]
What Do Analysts Have To Say About Adaptimmune Therapeutics Plc ADR (ADAP)
Adaptimmune Therapeutics Plc ADR (ADAP) saw downtrend of -5.67% in the recent trading with $1.33 being its most recent. The current price level -35.12% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 216.67% higher than the lowest price of $0.42 the company dropped […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock short term indicators tell us to Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 0.57% in the recent trading with $1.75 being its most recent. The current price level -5.41% lower than the highest price of $1.85 marked by the stock while trading over the past 52-weeks, whereas it is 316.67% higher than the lowest price of $0.42 the company […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock medium term indicators say Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 17.12% in the recent trading with $1.71 being its most recent. The current price level -4.47% lower than the highest price of $1.79 marked by the stock while trading over the past 52-weeks, whereas it is 307.14% higher than the lowest price of $0.42 the company […]
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) gain 7.25% – Is It right time to buy?
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 7.25% in the recent trading with $1.48 being its most recent. The current price level -20.00% lower than the highest price of $1.85 marked by the stock while trading over the past 52-weeks, whereas it is 252.38% higher than the lowest price of $0.42 the company […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock’s intermediate-term indicators point to Sell today
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 2.13% in the recent trading with $0.73 being its most recent. The current price level -63.19% lower than the highest price of $1.97 marked by the stock while trading over the past 52-weeks, whereas it is 72.64% higher than the lowest price of $0.42 the company […]
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) trading 109.52% higher than its 52 week low: What does Wall Street Say?
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 8.51% in the recent trading with $0.88 being its most recent. The current price level -62.55% lower than the highest price of $2.35 marked by the stock while trading over the past 52-weeks, whereas it is 109.52% higher than the lowest price of $0.42 the company […]